Health Care/Hospital

Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology Annual Meeting and Exposition

- Data spans eleven presentations across both solid tumors and hematologic malignancies, providing added understanding of the potential benefit these therapies bring to patients - ORSERDU data reinforce its key role in the treatment of ER+, HER2- advanced or metastatic breast cancer (mBC) tumors...

2023-11-21 20:15 2053

AXA and UMP announce strategic partnership Introducing inaugural outpatient clinic services to fulfil the medical needs of Hong Kong residents living and travelling to the mainland

Providing convenient and premium cross-border medical services for Greater Bay Area customers HONG KONG, Nov. 21, 2023 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") and UMP Healthcare Holdings Limited ("UMP", Stock Code: 722) jointly announced a strategic partnership to provide one-stop premiu...

2023-11-21 17:19 3178

Ignite Life for Future -- The 2023 International Forum on Life Science Held in Changping, Beijing

BEIJING, Nov. 21, 2023 /PRNewswire/ -- On November 18, the 2023 International Forum on Life Science was unveiled, under the theme of "Ignite Life for Future." Jointly organized by Beijing Municipal Science and Technology Commission, the Administrative Commission of Zhongguancun Science Park, the ...

2023-11-21 16:55 1867

HeiQ unveils HeiQ Skin Care - a probiotics-infused textile technology

ZÜRICH, Nov. 21, 2023 /PRNewswire/ -- HeiQ introduces a 100% biobased and long-lasting cosmetic finishing technology for textiles to the market.The newest addition to the HeiQ portfolio harnesses the power of active probiotics and selected prebiotics to enhance the skin microbiome, turning the hu...

2023-11-21 16:00 1737

JUMPSTARTER 2023 Tech by the Harbour Successfully Concludes

Allegrow Biotech in Biotech and Life Science Industry crowned champion of JUMPSTARTER 2023 Global Pitch Competition Two-week public event attracts over 100,000 participants HONG KONG, Nov. 21, 2023 /PRNewswire/ -- JUMPSTARTER, organized by Alibaba Hong Kong Entrepreneurs Fund ("AEF"), held its f...

2023-11-21 15:23 1903

Phyathai and Paolo Hospital Group Recognized for Corporate Excellence at the Asia Pacific Enterprise Awards 2023 Thailand

SINGAPORE, Nov. 20, 2023 /PRNewswire/ -- Phyathai and Paolo Hospital Group (Phyathai and Paolo) was honored with the Corporate Excellence Award at the Asia Pacific Enterprise Awards 2023 Thailand for its outstanding commitment to excellence throughout its 50 years of business. As a well-establish...

2023-11-21 09:54 1522

Innovative Breakthrough: Taiwan-BioActive Lipid (T-BAL) Redefines the Functional Food Landscape with Lipid Nanoparticles

TAICHUNG, Nov. 21, 2023 /PRNewswire/ -- In a groundbreaking stride within the functional food domain,Taiwan's Lipid Encapsulation and Analysis Corporation has harnessed the potential of Lipid Encapsulated Technology to unveil a revolutionary product line. Introducing nano-sized spheres adept at c...

2023-11-21 06:00 1437

Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation Leadership Award for Developing a Sophisticated Skin Tightening Ultrasound Technology with Minimal Downtime

Sofwave's Synchronous Ultrasound Parallel Beam (SUPERB™) technology significantly reduces downtime while offering outstanding results no matter the skin type. SAN ANTONIO, Nov. 20, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the non-invasive skin tightening industry and, based on i...

2023-11-20 21:30 1313

Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research

The power of advanced metabolomic analytical techniques can now be applied to a broader array of diverse academic and commercial life science research MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions adva...

2023-11-20 21:03 1301

Viva Biotech Secures Approximately US$ 210 Million Funding

HONG KONG, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Viva Biotech Holdings Group (1873. HK) announced thatit completed a funding round, securing approximatelyUS$210 million and bringing in the strategic investors, Temasek, Highlight Capital (HLC), and True Light. Following this transact...

2023-11-20 20:04 2757

Prenetics Announces Third Quarter 2023 Financial Results

HONG KONG, Nov. 20, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the third quarter endedSeptember 30, 2023, along with recent business updates. Third Quarter 20...

2023-11-20 19:30 2316

TSI Group Joins Halma Group, Unveiling New Avenues for Growth

SUGAR LAND, Texas, Nov. 20, 2023 /PRNewswire/ -- TeDan Surgical Innovations, a leading player in the medical technology sector, is thrilled to announce its inclusion in the Halma Group. This strategic move marks the formation of the TSI Group, which is comprised of TeDan Surgical Innovations, Wes...

2023-11-20 19:00 1902

Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023

The company will be presenting its growing pipeline of superb technologies for treating all four heart valves in its booth and at multiple events during the conference. HANGZHOU, China, Nov. 20, 2023 /PRNewswire/ -- Venus Medtech is changing how the world treats structural heart disease. The com...

2023-11-20 07:09 2064

Oncoclínicas has Net Profit of R$149 million (162% higher vs 3Q22) and Gross Revenue of R$1.5 billion in the third quarter

Operating Cash Generation was R$322 million, a record for the company's third quarter SÃO PAULO, Nov. 17, 2023 /PRNewswire/ -- Oncoclínicas & Co. (B3: ONCO3) reported a 23.4% increase in its gross revenue in the third quarter of 2023, reachingR$1.5 billion, another record for the company. The pe...

2023-11-17 22:10 2300

The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS

The SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility BOSTON and ROLLE, Switzerland, Nov. 17, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that the Institute of Human Gene...

2023-11-17 21:02 1644

Public Interest Registry Unveils Winners of 5th Annual .ORG Impact Awards at DC Ceremony Hosted by Padma Lakshmi

2023 .ORG of the Year, other award winners, selected from almost 1,000 applicants for impactful work to inspire, support their communities WASHINGTON, Nov. 17, 2023 /PRNewswire/ -- Public Interest Registry (PIR), the people behind .ORG, announced the winners of the.ORG Impact Awards, an annual p...

2023-11-17 21:00 1826

THE AIR STATION USHERS IN A NEW ERA IN SLEEP HEALTH WITH LAUNCH OF ITS ONE-STOP SLEEP SOLUTIONS STORE

* The Air Station emerges as a transformative force in the realm of sleep health, aiming to address sleep-related challenges. * Holistic approach to sleep empowerment through a comprehensive lineup of groundbreaking sleep health products that promote wellness and well-being. SINGAPORE, Nov. 1...

2023-11-17 17:48 1593

Fosun International Wins "Best in ESG Practices" and "Best in ESG Report" at TVB ESG Awards 2023

HONG KONG, Nov. 17, 2023 /PRNewswire/ -- On 9 November 2023, the TVB ESG Awards 2023 (the "Awards"), organized by Television Broadcasts Limited ("TVB") was held at the Hong Kong Convention and Exhibition Center. Fosun International was honored with "Best in ESG Practices" and "Best in ESG Report"...

2023-11-17 15:23 3191

Over 86 percent of Thai and Indonesian Women Consider Thalassemia Screening after Learning about Associated Health Risks

Thai (91.2%) and Indonesian (86.6%) women consider screening after learning about health risks and costs which is higher than the global average of 84.5% BANGKOK, Nov. 17, 2023 /PRNewswire/ -- According to Thailand's Ministry of Public Health , ...

2023-11-17 08:22 2077

Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Day

* Clinical programs, including ATG-101 (PD-L1/4-1BB bispecific antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), and ATG-037 (oral CD73 inhibitor) have shown clinical responses in cancer patients with advanced diseases. * ATG-008 (dual mTORC1/2 inhibitor) continued showing strong cli...

2023-11-17 08:00 2107
1 ... 949596979899100 ... 570